Advocate for People with Neuroendocrine Cancer
Advocacy is a powerful way to create change.
By raising your voice, you can help NECA push for better access to diagnosis, treatment, and support for people living with neuroendocrine cancer. Together we can make a difference.
Help us drive change.
Improve care for Australians living with neuroendocrine cancer.
-
Neuroendocrine cancer is the seventh most common cancer in Australia, yet too many people still face long waits for diagnosis, limited access to specialists, and challenges navigating the health system. Advocacy helps change this. When people affected by neuroendocrine cancer, their carers, families and friends raise their voices, governments listen and take meaningful action.
Advocacy helps to:
- Draw national attention to the gaps in care and the barriers people with neuroendocrine cancer face
- Highlight the need for better pathways to diagnosis and coordinated care
- Support calls for more specialist NET nurses and services in priority areas
- Strengthen the case for fair access to scans, medicines, and clinical trials
- Encourage investment in research and improved national data
- Build understanding of neuroendocrine cancer across government and the community
Every voice makes a difference. Your support helps us push for real improvements in care and outcomes.
-
Your advocacy can help shape a fairer, more responsive health system. By engaging with government and the community, you can influence:
- Improved pathways to diagnosis
Sharing your experience helps bring attention to the need for earlier detection, better access to imaging, and clearer clinical pathways. - Better access to specialist care
Advocacy strengthens the case for more NET nurses, multidisciplinary care, and services in areas where support is limited. - Fair and timely access to treatment and medicines
By raising awareness of barriers in accessing approved treatments, you help ensure people with neuroendocrine cancer are considered in policy and funding decisions. - Investment in research and national data
Public advocacy can highlight the importance of accurate data, research funding, and better tracking of neuroendocrine cancer incidence and outcomes. - Greater public and government awareness
Every story shared helps build understanding of neuroendocrine cancer and the real impact it has on individuals, families, and communities.
- Improved pathways to diagnosis
-
There are many ways to take action and support better outcomes for Australians living with neuroendocrine cancer. Whether you have a few minutes or a few hours, your contribution matters.
Ways to Advocate
- Email your local MPÂ using our advocacy priorities and letter templates
- Share your NET story with NECA or on social media to raise awareness
- Support national campaigns like World Neuroendocrine Cancer Day each November
- Attend NECA Parliamentary Events and community advocacy activities
- Host or join local awareness initiatives such as information sessions or fundraising events
These actions help amplify the needs of the NET community across Australia.
-
To make advocacy easy, we provide resources that you can download and use right away.
Advocacy Resources
- MP Letter Templates ready for you to personalise and send
- Social Media Tiles to help spread awareness online
- NET Key Facts Sheet for sharing within your community or electorate
- Policy Submissions and Reports so you can stay informed about NECA’s work with government
These tools are designed to help you speak confidently and effectively about the changes needed in NET care.
Our Current Priorities and Latest Wins
These achievements show what is possible when our community stands together.
Our Current Priorities
- Funding for specialist NET nurses, including expanding services for priority populations and rural / remote regions
- Improving diagnostic pathways to reduce long wait times
- Ensuring fair access to medicines through the HTA review
- Encouraging government action on recommendations from the Senate Inquiry
- Improving access to clinical trials across Australia to ensure people with neuroendocrine cancer’s are not disadvantaged by geography or limited trial availability
Our Recent Wins
- Belzutifan listed on the PBS for eligible Australians following sustained advocacy from patients, clinicians, and organisations like NECA. This milestone improves access to an important therapy and highlights the power of collective advocacy.
- Strong Government response supporting 31 of 41 recommendations from the Senate Inquiry
- Increased Parliamentary support for improved NET care across multiple states
- National media coverage and growing community awareness
- Expanded access to NECA support services including nursing, counselling, and dietetics
- Successful Parliamentary events highlighting patient voices and clinical expertise